- Home
- SOC vs RVNC Comparison
SOC vs RVNC Comparison
Compare SOC & RVNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SOC
- RVNC
- Stock Information
- Founded
- SOC 2020
- RVNC 1999
- Country
- SOC United States
- RVNC United States
- Employees
- SOC N/A
- RVNC N/A
- Industry
- SOC
- RVNC Biotechnology: Pharmaceutical Preparations
- Sector
- SOC
- RVNC Health Care
- Exchange
- SOC Nasdaq
- RVNC Nasdaq
- Market Cap
- SOC 2.0B
- RVNC 320.5M
- IPO Year
- SOC N/A
- RVNC 2014
- Fundamental
- Price
- SOC $24.56
- RVNC $3.07
- Analyst Decision
- SOC Buy
- RVNC Hold
- Analyst Count
- SOC 3
- RVNC 9
- Target Price
- SOC $25.00
- RVNC $7.78
- AVG Volume (30 Days)
- SOC 1.6M
- RVNC 3.4M
- Earning Date
- SOC 02-20-2025
- RVNC 02-26-2025
- Dividend Yield
- SOC N/A
- RVNC N/A
- EPS Growth
- SOC N/A
- RVNC N/A
- EPS
- SOC N/A
- RVNC N/A
- Revenue
- SOC N/A
- RVNC $256,945,000.00
- Revenue This Year
- SOC N/A
- RVNC $11.28
- Revenue Next Year
- SOC $606.07
- RVNC $27.21
- P/E Ratio
- SOC N/A
- RVNC N/A
- Revenue Growth
- SOC N/A
- RVNC 25.82
- 52 Week Low
- SOC $10.11
- RVNC $2.30
- 52 Week High
- SOC $28.67
- RVNC $9.75
- Technical
- Relative Strength Index (RSI)
- SOC 59.87
- RVNC 33.02
- Support Level
- SOC $21.99
- RVNC $3.06
- Resistance Level
- SOC $24.53
- RVNC $3.09
- Average True Range (ATR)
- SOC 1.59
- RVNC 0.02
- MACD
- SOC 0.38
- RVNC 0.05
- Stochastic Oscillator
- SOC 86.97
- RVNC 44.44
About SOC Sable Offshore Corp. Common Stock
Sable Offshore Corp is a Houston-based independent upstream company focused on responsibly developing the prolific Santa Ynez Unit in federal waters offshore California.
About RVNC Revance Therapeutics Inc.
Revance Therapeutics Inc is a biotechnology company focused on aesthetic and therapeutic offerings, including its neuromodulator product, DaxibotulinumtoxinA for Injection. The company has launched a prestige aesthetics portfolio, which includes the RHA Collection of dermal fillers and the HintMD platform. Its main products include DaxibotulinumtoxinA for Injection and DaxibotulinumtoxinA for Injection Aesthetics. The operating business segments are the Product and the Service Segment. The Products segment generates maximum revenue and is engaged in the research and development of aesthetic and therapeutic products.